Omada Health is trading at $19.70, down 8.37%, with no reliable company-specific announcement or analyst action identified to explain the decline.
- Broader U.S. markets were rising on September 11, 2026.
- At its September 10 investor day, the company presented targets of at least 20% annual revenue growth, 80% non-GAAP gross margin, and 30% adjusted EBITDA margin.
- Volume data was unavailable.